We are live on ! Find out more
WCM

Wildcat Capital Management Portfolio holdings

AUM $229M
1-Year Est. Return 132.65%
This Fund
S&P 500
This Quarter Est. Return
+33.14%
1 Year Est. Return
+132.65%
3 Year Est. Return
+125.67%
5 Year Est. Return
+54.1%
10 Year Est. Return
+1,929.91%
AUM
$376M
AUM Growth
+$60.4M
Cap. Flow
-$25.4M
Cap. Flow %
-6.75%
Top 10 Hldgs %
96.97%
Holding
22
New
7
Increased
3
Reduced
2
Closed
4

Top Sells

Rank Stock Value
1
MDXG icon
MiMedx Group
MDXG
+$14.4M
2
IBRX icon
ImmunityBio
IBRX
+$4.73M
3
CSGP icon
CoStar Group
CSGP
+$2.18M

Sector Composition

Rank Sector Weight
1 Real Estate 14.49%
2 Healthcare 7.69%
3 Financials 2.34%
4 Consumer Discretionary 1.7%
5 Energy 0.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KITE
1
DELISTED
Kite Pharma, Inc.
KITE
$250M 66.42%
2,410,034
+51,950
+2% +$4.24M
CSGP icon
2
CoStar Group
CSGP
$11.7B
$47.9M 12.73%
1,816,720
-89,650
-5% -$2.18M
IBRX icon
3
ImmunityBio
IBRX
$7.51B
$25.7M 6.84%
3,391,539
-1,093,956
-24% -$4.73M
LPLA icon
4
LPL Financial
LPLA
$28.3B
$8.8M 2.34%
208,401
+1,754
+0.8% +$71.2K
EMB icon
5
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$7.94M 2.11%
70,000
UNIT
6
Uniti Group
UNIT
$2.36B
$6.61M 1.76%
263,000
+100,000
+61% +$2.59M
MDXG icon
7
CALL
MiMedx Group
MDXG
$602M
$5.85M 1.56%
+391,000
New +$5.22M
SRNE
8
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$5.6M 1.49%
2,799,790
PLYA
9
DELISTED
Playa Hotels & Resorts
PLYA
$3.58M 0.95%
+300,000
New +$3.16M
SBR
10
Sabine Royalty Trust
SBR
$1.06B
$2.86M 0.76%
+74,505
New +$2.78M
BABA icon
11
Alibaba
BABA
$293B
$2.83M 0.75%
+20,068
New +$2.48M
FXY icon
12
Invesco CurrencyShares Japanese Yen Trust
FXY
$438M
$2.67M 0.71%
31,245
URGN icon
13
UroGen Pharma
URGN
$1.86B
$2.44M 0.65%
+135,000
New +$2.34M
NH
14
DELISTED
NantHealth, Inc
NH
$1.01M 0.27%
15,922
FXE icon
15
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$346M
$997K 0.27%
+9,023
New +$963K
UUP icon
16
CALL
Invesco DB US Dollar Index Bullish Fund
UUP
$420M
$728K 0.19%
+29,400
New +$747K
EDIT icon
17
Editas Medicine
EDIT
$396M
$693K 0.18%
41,324
ADVM
18
DELISTED
Adverum Biotechnologies
ADVM
$38K 0.01%
1,500
MDXG icon
19
MiMedx Group
MDXG
$602M
-1,080,365
Closed -$14.4M
OEF icon
20
CALL
iShares S&P 100 ETF
OEF
$20.1B
-9,560
Closed -$2.8M
TSLA icon
21
PUT
Tesla
TSLA
$1.23T
-16,500
Closed -$306K
UUP icon
22
PUT
Invesco DB US Dollar Index Bullish Fund
UUP
$420M
-985,100
Closed -$25.6M

Similar funds

Wildcat Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Wildcat Capital Management held 22 positions worth $376M, up 19% from $316M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Wildcat Capital Management withdrew a net $25.4M in Q2 2017, closing 4 positions and reducing 2 holdings. Its most notable exit was MiMedx Group, an estimated $14.4M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Wildcat Capital Management opened a new position in Playa Hotels & Resorts worth $3.58M.

  • Wildcat Capital Management's largest Q2 2017 buy was Playa Hotels & Resorts: 300,000 shares worth $3.58M.
  • Wildcat Capital Management added most to Kite Pharma, Inc. in Q2 2017, an estimated $4.24M increase.
  • Wildcat Capital Management's biggest Q2 2017 reduction was ImmunityBio, cutting an estimated $4.73M.
  • Wildcat Capital Management fully exited MiMedx Group in Q2 2017, selling an estimated $14.4M.
  • Wildcat Capital Management's ten largest holdings make up 97% of its $376M portfolio in Q2 2017.
  • Wildcat Capital Management opened 7 new positions and closed 4 in Q2 2017.
  • Wildcat Capital Management's portfolio value rose 19% quarter-over-quarter to $376M.

Based on Wildcat Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.